Active · per the CBE, 16 September 2026
REACH Orphan Substances Consortium logo

REACH Orphan Substances Consortium

BE0630838609

Rechtspersoon Private limited company 1 establishment

REACH Orphan Substances Consortium is filed with the CBE under the catch-all “Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten”, a code that says little about what the company actually does. Private Limited, started on 21 May 2015, 1 establishment.

Haverstraat 8, 2350 Vosselaar rosconsortium.eu [email protected]

Behind the company: Karine Van de Velde.

Active for

11 year, 3 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 30 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

REACH Orphan Substances Consortium from Vosselaar, company number BE0630838609, closed financial year 2025 with a result of € 0 after tax. For that financial year REACH Orphan Substances Consortium recorded a gross margin of € -6,176 and equity of € 6,200. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Healthy

€ 6,200

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit

€ 0

Profit after tax over the fiscal year.

Cash in the bank

€ 253,465

▲ 110% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 0.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 96,132

▲ € 82,967 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 2,361 € -1,694 € -1,861 € -6,176 ▼ € 4,315
Equity € 6,200 € 6,200 € 6,200 € 6,200
Total debts € 1,263,680 € 1,089,784 € 996,247 € 1,184,873 ▲ 19%
Cash € 1,255,785 € 210,938 € 120,623 € 253,465 ▲ 110%
Balance sheet total € 1,269,880 € 1,095,984 € 1,002,447 € 1,191,073 ▲ 19%

Key figures of REACH Orphan Substances Consortium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to REACH Orphan Substances Consortium?

What happened at REACH Orphan Substances Consortium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
  • New establishment in Vosselaar. KBO
  • Start of the company according to the CBE. KBO

In short

From € 0 profit in 2022 to € 0 profit in 2025.

Management

Karine Van de Velde
REACH Orphan Substances Consortium

Behind REACH Orphan Substances Consortium is Karine Van de Velde. Karine Van de Velde is also behind KV CONSULTING SERVICES.

See the full network in the app

Directors

According to the 2025 annual accounts

Karine Van de Velde

Director

Also active at: KV CONSULTING SERVICES

Establishments

Establishment units

Physical locations of this company

Registered office

Haverstraat 8

2350 Vosselaar

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

BootstrapFont AwesomeGoogle FontsNginxPHPWooCommerceWordPressjQuery

Hosting & Email

Email provider

Microsoft 365

Hosting

TELENET-AS, BE

Domain

Domain

rosconsortium.eu

Registrar

Telenet NV (Hosting & Cloud)

Website info

HTTPS Ja
Indexable pages 8
Languages EN

Features

Webshop

Security

HTTPS
SPF
DMARC

Details

Company number
0630.838.609
VAT number
BE 0630.838.609
Registered office
Haverstraat 8, 2350 Vosselaar
Names & denominations
REACH Orphan Substances Consortium · ROSC
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
21 May 2015
Peppol
Active · Active since 12 Nov 2025
Activities · NACE

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige gespecialiseerde wetenschappelijke en technische activiteiten

Overige zakelijke dienstverlening, neg

Frequently asked questions

What does REACH Orphan Substances Consortium do?
REACH Orphan Substances Consortium is filed with the CBE under the catch-all “Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten”, a code that says little about what the company actually does. Private Limited, started on 21 May 2015, 1 establishment.
What is the address of REACH Orphan Substances Consortium?
The registered office of REACH Orphan Substances Consortium is located at Haverstraat 8, 2350 Vosselaar.
Is REACH Orphan Substances Consortium still active?
Yes. According to the CBE (16 September 2026) REACH Orphan Substances Consortium is active, legal situation “Normale toestand”, started on 21 May 2015.
Is REACH Orphan Substances Consortium registered on Peppol?
Yes, REACH Orphan Substances Consortium is registered on the Peppol network with ID 0208:0630838609.
What is the enterprise number of REACH Orphan Substances Consortium?
The enterprise number of REACH Orphan Substances Consortium is BE0630838609.
When was REACH Orphan Substances Consortium founded?
REACH Orphan Substances Consortium was founded on 21 May 2015.